PICTET ASSET MANAGEMENT SA 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-03 11:51 am Sale | 2022-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | PICTET ASSET MANAGEMENT SA | 1,234,193 3.570% | -2,314,456 (-65.22%) | Filing |
| 2022-02-10 11:07 am Purchase | 2021-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | PICTET ASSET MANAGEMENT SA | 3,548,649 5.150% | 3,548,649 (New Position) | Filing |